|
RRP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.014800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.437800E-01 |
| Normal-vs-Stage2 |
3.615600E-01 |
| Normal-vs-Stage3 |
4.217600E-03 |
| Normal-vs-Stage4 |
3.074600E-01 |
| Stage1-vs-Stage2 |
3.453200E-01 |
| Stage1-vs-Stage3 |
3.557300E-03 |
| Stage1-vs-Stage4 |
2.228600E-01 |
| Stage2-vs-Stage3 |
1.062200E-01 |
| Stage2-vs-Stage4 |
7.033600E-01 |
| Stage3-vs-Stage4 |
3.686000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.499630E-01 |
| Normal-vs-AfricanAmerican |
7.799200E-01 |
| Normal-vs-Asian |
1.229600E-01 |
| Caucasian-vs-AfricanAmerican |
2.851000E-01 |
| Caucasian-vs-Asian |
1.739380E-01 |
| AfricanAmerican-vs-Asian |
1.349010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.758200E-01 |
| Normal-vs-Female |
1.379900E-02 |
| Male-vs-Female |
1.275880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.690560E-01 |
| Normal-vs-Extreme_Weight |
3.542200E-01 |
| Normal-vs-Obese |
2.682800E-01 |
| Normal-vs-Extreme_Obese |
2.567200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.774800E-01 |
| Normal_Weight-vs-Obese |
7.685800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.478000E-02 |
| Extreme_Weight-vs-Obese |
7.568800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.046010E-01 |
| Obese-vs-Extreme_Obese |
1.811010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.258800E-03 |
| Normal-vs-Age(41-60Yrs) |
6.575600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.333800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.001800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.564700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.322500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.019700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.745600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.539800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.749770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.700200E-01 |
| Normal-VS-Type2 PRCC |
5.087600E-02 |
| Normal-VS-KIRP CIMP |
1.528160E-02 |
| Normal-VS-Unclassified PRCC |
3.466600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.318200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.787960E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.588000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.719700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.696000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.541400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.857400E-01 |
| Normal-vs-N1 |
1.772200E-02 |
| Normal-vs-N2 |
6.255400E-01 |
| N0-vs-N1 |
7.562500E-02 |
| N0-vs-N2 |
7.327600E-01 |
| N1-vs-N2 |
5.961400E-01 |
|
|
